These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32261739)
1. Peptide-based isolation of circulating tumor cells by magnetic nanoparticles. Bai L; Du Y; Peng J; Liu Y; Wang Y; Yang Y; Wang C J Mater Chem B; 2014 Jul; 2(26):4080-4088. PubMed ID: 32261739 [TBL] [Abstract][Full Text] [Related]
2. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles. Liang N; Liu L; Li P; Xu Y; Hou Y; Peng J; Song Y; Bing Z; Wang Y; Wang Y; Jia Z; Yang X; Li D; Xu H; Yu Q; Li S; Hu Z; Yang Y J Thorac Dis; 2020 Aug; 12(8):4262-4273. PubMed ID: 32944338 [TBL] [Abstract][Full Text] [Related]
3. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles. Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122 [TBL] [Abstract][Full Text] [Related]
4. Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection. Jia F; Wang Y; Fang Z; Dong J; Shi F; Zhang W; Wang Z; Hu Z Anal Chem; 2021 Apr; 93(14):5670-5675. PubMed ID: 33788544 [TBL] [Abstract][Full Text] [Related]
5. Tannic Acid (TA)-Functionalized Magnetic Nanoparticles for EpCAM-Independent Circulating Tumor Cell (CTC) Isolation from Patients with Different Cancers. Ding P; Wang Z; Wu Z; Hu M; Zhu W; Sun N; Pei R ACS Appl Mater Interfaces; 2021 Jan; 13(3):3694-3700. PubMed ID: 33442969 [TBL] [Abstract][Full Text] [Related]
6. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells. Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336 [TBL] [Abstract][Full Text] [Related]
7. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system. Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409 [TBL] [Abstract][Full Text] [Related]
8. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'. Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987 [TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients. Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504 [TBL] [Abstract][Full Text] [Related]
10. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen. Johnson ES; Anand RK; Chiu DT Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174 [TBL] [Abstract][Full Text] [Related]
11. Peptide-Functionalized Nanomaterials for the Efficient Isolation of HER2-Positive Circulating Tumor Cells. Peng J; Zhao Q; Zheng W; Li W; Li P; Zhu L; Liu X; Shao B; Li H; Wang C; Yang Y ACS Appl Mater Interfaces; 2017 Jun; 9(22):18423-18428. PubMed ID: 28523908 [TBL] [Abstract][Full Text] [Related]
12. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
13. Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation. Pipatwatcharadate C; Iyer PR; Pissuwan D Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896242 [TBL] [Abstract][Full Text] [Related]
14. Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients. Cha J; Cho H; Chung JS; Park JS; Han KH Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345161 [TBL] [Abstract][Full Text] [Related]
15. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System. Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728 [TBL] [Abstract][Full Text] [Related]
16. An Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic System for the Isolation of High-Purity CD45 Liao CJ; Hsieh CH; Chiu TK; Zhu YX; Wang HM; Hung FC; Chou WP; Wu MH Micromachines (Basel); 2018 Oct; 9(11):. PubMed ID: 30715062 [TBL] [Abstract][Full Text] [Related]
17. Design of a Biocompatible and Ratiometric Fluorescent probe for the Capture, Detection, Release, and Reculture of Rare Number CTCs. Yu Y; Yang Y; Ding J; Meng S; Li C; Yin X Anal Chem; 2018 Nov; 90(22):13290-13298. PubMed ID: 30345741 [TBL] [Abstract][Full Text] [Related]
18. Folic Acid Targeting for Efficient Isolation and Detection of Ovarian Cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy. Nie L; Li F; Huang X; Aguilar ZP; Wang YA; Xiong Y; Fu F; Xu H ACS Appl Mater Interfaces; 2018 Apr; 10(16):14055-14062. PubMed ID: 29620849 [TBL] [Abstract][Full Text] [Related]
19. Comparative study on antibody immobilization strategies for efficient circulating tumor cell capture. Ates HC; Ozgur E; Kulah H Biointerphases; 2018 Mar; 13(2):021001. PubMed ID: 29571263 [TBL] [Abstract][Full Text] [Related]
20. Functional and biocompatible polymeric ionic liquid (PIL) - Decorated immunomagnetic nanospheres for the efficient capture of rare number CTCs. Yu Y; Yang Y; Wang F; Ding J; Meng S; Li C; Tang D; Yin X Anal Chim Acta; 2018 Dec; 1044():162-173. PubMed ID: 30442398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]